IP Library Granted Patent US 11,557,393
Granted Patent B2
US 11,557,393 · App. 17/177,914 · Granted Jan 17, 2023

Medication tracking

Inventors: Jennifer Ashley Gitchell (Washington, DC); Timothy James Leo Kress-Spatz (Arlington, VA); Kevin William MacDonald (Miami, FL); Nicholas Bastien Petersen (Washington, DC); Julie Christina Meloni (Washington, DC); Christian Lee Doyle (Silver Spring, MD); Michael David Waud (Washington, DC); David Mario Pedra (Washington, DC); Nicholas Ward Stocchero (Washington, DC); Michael Christopher Wimpee (Washington, DC); Steven Shyu (Washington, DC); Mahesh Murali (Washington, DC)
Assignee: Kit Check, Inc.
G16H40/20A61J1/00A61J1/18G06K7/10366G06Q10/087G06Q50/22G16Z99/00A61G12/001A61J2205/30A61J2205/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,557,393
App. No.
17/177,914
Granted
Jan 17, 2023
Kind
B2
Abstract

A system and method is described for printing a label with an RFID tag. The system includes an RFID reader that queries a first RFID tag coupled to a first medicinal container that includes a medication. In response, the system receives a first unique identifier and uses the first unique identifier to determine a status of the medication, associate the first medicinal container with a medical provider and print a second label that includes a second RFID tag for a second medicinal container.

Claims (41)

1. A system comprising:

one or more processors configured to:

receive a first unique identifier, wherein the first unique identifier corresponds to a first computer-readable code associated with a first medicinal container configured to store a first medication,

receive a second unique identifier, wherein the second unique identifier corresponds to a second computer-readable code associated with a second medicinal container configured to store a second medication,

requesting, from a remotely located database, first drug data using the first unique identifier and second drug data using the second unique identifier, wherein the first drug data corresponds to the first medication and the second drug data corresponds to the second medication;

determine a drug expiration date of a third medication using the first drug data and the second drug data, wherein the third medication comprises at least a portion of the first medication and the second medication, and

update the remotely located database to associate the drug expiration date of the third medication with a third unique identifier, wherein the third unique identifier corresponds to a third computer-readable code that is associated with the third medication.

2. The system of claim 1 , wherein the one or more processors are further configured to:

receive the third unique identifier; and

update drug data of the remotely located database to associate the third medication with the third unique identifier.

3. The system of claim 1 , wherein to determine the drug expiration date, the one or more processors are configured to:

determine a first expiration date using the first drug data, wherein the first expiration date corresponds to an expiration date of the first medication;

determine a second expiration date using the second drug data, wherein the second expiration date corresponds to an expiration date of the second medication; and

identify the drug expiration date as an earlier of the first expiration date and the second expiration date.

4. The system of claim 1 , wherein to determine the drug expiration date, the one or more processors are configured to determine the drug expiration date using a predefined rule set corresponding to a combination of the first medication and the second medication.

5. The system of claim 1 , wherein the one or more processors are further configured to update an expiration date of at least one of the first medication or the second medication to reflect that a sterile barrier has been pierced.

6. The system of claim 1 , further comprising an RFID reader, configured to obtain the first unique identifier from an RFID tag.

7. The system of claim 1 , further comprising a barcode scanner configured to obtain the first unique identifier from a barcode.

8. The system of claim 1 , wherein the one or more processors are configured to concurrently receive the first unique identifier and the second unique identifier.

9. The system of claim 1 , wherein the one or more processors are configured to successively receive the first unique identifier and the second unique identifier.

10. The system of claim 1 , wherein the one or more processors are further configured to update the remotely located database to associate the third medication with each of the first medication and the second medication.

11. A method comprising:

receiving, a first unique identifier, wherein the first unique identifier corresponds to a first computer-readable code associated with a first medicinal container configured to store a first medication,

receiving, a second unique identifier, wherein the second unique identifier corresponds to a second computer-readable code associated with a second medicinal container configured to store a second medication,

requesting, from a remotely located database, first drug data using the first unique identifier and second drug data using the second unique identifier, wherein the first drug data corresponds to the first medication and the second drug data corresponds to the second medication;

determining a drug expiration date of a third medication using the first drug data and the second drug data, wherein the third medication comprises at least a portion of the first medication and the second medication, and

updating the remotely located database to associate the drug expiration date of the third medication with a third unique identifier, wherein the third unique identifier is associated with the third medication.

12. The method of claim 11 , further comprising:

receiving, the third unique identifier; and

updating the drug data of the remotely located database to associate the third medication with the third unique identifier.

13. The method of claim 11 , wherein said determining the drug expiration date comprises:

determining a first expiration date using the first drug data, wherein the first expiration date corresponds to an expiration date of the first medication;

determining a second expiration date using the second drug data, wherein the second expiration date corresponds to an expiration date of the second medication; and

identifying the drug expiration date as an earlier of the first expiration date and the second expiration date.

14. The method of claim 11 , wherein said determining the drug expiration date is using a predefined rule set corresponding to a combination of the first medication and the second medication.

15. The method of claim 11 , further comprising updating an expiration date of at least one of the first medication or the second medication to reflect that a sterile barrier has been pierced.

16. The method of claim 11 , further comprising an RFID reader, configured to obtain the first unique identifier from an RFID tag.

17. The method of claim 11 , further comprising a barcode scanner configured to obtain the first unique identifier from a barcode.

18. The method of claim 11 , further comprising concurrently receiving the first unique identifier and the second unique identifier.

19. The method of claim 11 , further comprising successively receiving the first unique identifier and the second unique identifier.

20. The method of claim 11 , further comprising updating the remotely located database to associate the third medication with each of the first medication and the second medication.

Assignments (6)
RELEASE OF SECURITY INTEREST AT R/F 46235/0172 Recorded Jul 18, 2023
From: ORIX GROWTH CAPITAL, LLC
To: BLUESIGHT, INC. (F/K/A KIT CHECK, INC.)
Reel/Frame 064309/0352 →
SECURITY INTEREST Recorded Jul 17, 2023
From: BLUESIGHT, INC.
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS COLLATERAL AGENT
Reel/Frame 064284/0736 →
CHANGE OF NAME Recorded Feb 16, 2023
From: KIT CHECK, INC.
To: BLUESIGHT, INC.
Reel/Frame 062775/0703 →
SECURITY INTEREST Recorded Nov 4, 2021
From: KIT CHECK, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 058018/0443 →
CORRECTIVE ASSIGNMENT TO CORRECT THE FOURTH ASSIGNOR NAME FROM NICOLAS BASTIEN PETERSEN TO NICHOLAS BASTIEN PETERSEN PREVIOUSLY RECORDED ON REEL 055373 FRAME 0070. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Feb 26, 2021
From: GITCHELL, JENNIFER ASHLEY; KRESS-SPATZ, TIMOTHY JAMES LEO; MACDONALD, KEVIN WILLIAM; PETERSEN, NICHOLAS BASTIEN; MELONI, JULIE CHRISTINA; DOYLE, CHRISTIAN LEE; WAUD, MICHAEL DAVID; PEDRA, DAVID MARIO; STOCCHERO, NICHOLAS WARD; WIMPEE, MICHAEL CHRISTOPHER; SHYU, STEVEN; MURALI, MAHESH
To: KIT CHECK, INC.
Reel/Frame 056421/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: GITCHELL, JENNIFER ASHLEY; KRESS-SPATZ, TIMOTHY JAMES LEO; MACDONALD, KEVIN WILLIAM; PETERSEN, NICOLAS BASTIEN; MELONI, JULIE CHRISTINA; DOYLE, CHRISTIAN LEE; WAUD, MICHAEL DAVID; PEDRA, DAVID MARIO; STOCCHERO, NICHOLAS WARD; WIMPEE, MICHAEL CHRISTOPHER; SHYU, STEVEN; MURALI, MAHESH
To: KIT CHECK, INC.
Reel/Frame 055373/0070 →
Continuity (10)
Continuation 16822459 · Mar 18, 2020
Continuation 16103001 · Aug 14, 2018
Continuation 15426302 · Feb 7, 2017
Continuation 14876533 · Oct 6, 2015
Continuation 14563732 · Dec 8, 2014
Provisional Application 62062845 · Oct 11, 2014
Provisional Application 62020576 · Jul 3, 2014
Provisional Application 62000570 · May 20, 2014
Provisional Application 61913337 · Dec 8, 2013
Related Publication 20210241891A1 · Aug 5, 2021
Cited By (6)
US 12,400,746 US 12,443,920 US 12,494,283 US 12,515,829 US 12,626,817 US 12,712,059